Company Profiles

driven by the PitchBook Platform

Valerion Therapeutics

Description

Developer of therapies for orphan genetic muscle diseases. The company uses antibody-mediated delivery platform to target therapies to specific tissues that enhances intracellular delivery of a variety of active therapeutic payloads via a transport mechanism that is present in muscle and neurons and elevated in certain types of cancer.

2007

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$10M

Latest Deal Amount

$32.9M

Total Amount Raised

Description

Developer of therapies for orphan genetic muscle diseases. The company uses antibody-mediated delivery platform to target therapies to specific tissues that enhances intracellular delivery of a variety of active therapeutic payloads via a transport mechanism that is present in muscle and neurons and elevated in certain types of cancer.

Website:

www.valerion.com

Formerly Known As

4s3 Bioscience

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Delivery

Primary Office

100 Main Street Suite 110 Concord, MA 01742United States +1 (978) 341-8183
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Valerion Therapeutics's full profile, request a free trial.

Valerion Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Valerion Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Valerion Therapeutics Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alopexx EnterprisesCorporate Venture CapitalMinority000 0000000 0000
KLP EnterprisesVenture CapitalMinority000 0000000 0000
MDA Venture PhilanthropyVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
Sanofi-Genzyme BioventuresCorporate Venture CapitalMinority000 0000000 0000
Alopexx Enterprises Corporate Venture Capital
KLP Enterprises Venture Capital
MDA Venture Philanthropy Venture Capital
National Institutes of Health Government
Sanofi-Genzyme Bioventures Corporate Venture Capital

Valerion Therapeutics Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Deborah RamsdellChief Executive Officer, President & Board Member
Dustin Armstrong Ph.DFounder, Chief Scientific Officer, Board Member Secretary & Treasurer
Hal Landy MDChief Medical Officer
Deborah Ramsdell Chief Executive Officer, President & Board Member
Dustin Armstrong Ph.D Founder, Chief Scientific Officer, Board Member Secretary & Treasurer
Hal Landy MD Chief Medical Officer

Valerion Therapeutics Board Members (5)

NameRepresentingRoleSinceContact
Info
Andre TurenneGenzymeHead of Strategy & Business Development000 0000
Christine Del los ReyesSelfBoard Member000 0000
Daniel VlockSelfChairman000 0000
Dustin Armstrong Ph.DValerion TherapeuticsFounder, Chief Scientific Officer, Board Member Secretary & Treasurer000 0000
Randy WingateSelfBoard Member000 0000
Andre Turenne Head of Strategy & Business Development Genzyme
Christine Del los Reyes Board Member Self
Daniel Vlock Chairman Self
Dustin Armstrong Ph.D Founder, Chief Scientific Officer, Board Member Secretary & Treasurer Valerion Therapeutics
Randy Wingate Board Member Self
Request full access to PitchBook